DGAT1-IN-3,also known as RO-5006036, is a novel,potent, selective and orally bioavailable inhibitor of DGAT-1, with IC50s of 38 nM for human DGAT-1 and 120 nM for rat DGAT-1.

PF-06424439 Mesylate, the mesylate salt of PF06424439, is a novel and potent inhibitor of diacylglycerol acyltransferase 2 (DGAT2, IC50 = 14 nM) with lipid lowering effects.

Rubimaillin (Mollugin) is a naturally occuring naphthohydroquinone extracted from Rubia cordifolia L. with anticancer activity.

ABT-046 is a novel, potent, selective, and orally bioavailableinhibitor of diacylglycerol acyltransferase 1 (DGAT-1 ) with IC50 of 8 nM.

Glabrol is natural product of the flavonoid class.

Pradigastat (formerly also known as LCQ-908; LCQ908) is a novel, potent and orally bioavailable diacylglycerol acyltransferase 1 (DGAT1) inhibitor being developed for the treatment of familial chylomicronemia syndrome.

PF-06471553 (PF06471553) is a novel, potent, selective and orally bioavailable monoacylglycerol acyltransferase 3 (MGAT3) inhibitor with the potential to treat insulin resistance, diabetes, dyslipidemia, and hepatic steatosis.

DGAT1-IN-1 is a potent DGAT1 inhibitor.